A further understanding of the mechanisms underlying HIF-1α-independent induction of VEGF may provide therapeutic strategies for controlling angiogenesis enhanced by factors of the tumor microenvironment, such as BM-MSC secretions. The gene discussed is VEGFA; the disease is neoplasm.